Nova Wealth Management, Inc.

Source: SEC Form 13F · as of Mar 2026

Nova Wealth Management, Inc. holds 22 biotech & pharma companies tracked by BioSniper, totaling $517K in value as of Mar 2026 (SEC Form 13F).

Companies held

22

Total value held

$517K

CompanySharesValue
LLYELI LILLY & Co254$233K
JNJJOHNSON & JOHNSON378$93K
UNHUnitedHealth Group Incorporated Common Stock (DE)214$58K
AMGNAMGEN INC72$25K
ABTABBOTT LABORATORIES230$24K
PMPhilip Morris International Inc91$15K
MRKMerck & Co., Inc.90$11K
ZTSZoetis Inc.88$10K
ABBVAbbVie Inc.34$7K
GILDGILEAD SCIENCES, INC.50$7K
VRTXVERTEX PHARMACEUTICALS INC / MA14$6K
NVSNovartis AG38$6K
MCKMcKesson Corporation6$5K
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)90$5K
CAHCardinal Health Inc.19$4K
ELANElanco Animal Health Inc90$2K
GEHCGE HealthCare Technologies Inc.20$1K
MOHMolina Healthcare Inc10$1K
INVAInnoviva, Inc.50$1K
TBPHTheravance Biopharma, Inc.42$682
NVONovo Nordisk A/S15$551
SCNXScienture Holdings, Inc.30$9

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Nova Wealth Management, Inc. — Biotech 13F Holdings & Portfolio | BioSniper